In the last decades, tremendous advancement in dissecting the mechanisms of
pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting …

The protein composition of an Outer Membrane Vesicle (OMV) preparation that constitutes
the active pharmaceutical ingredient of VA-MENGOC-BC®, an effective vaccine against …

Klebsiella pneumoniae is a hospital-acquired pathogen that leads to various infections.
There is a great interest in developing an efficient Klebsiella vaccine and epitope-based …

Mycoplasma pneumoniae is the prevalent cause of acquired respiratory infections around
the globe. A multi-epitope vaccine (MEV) must be developed to combat infections of M …

Chagas disease, caused by Trypanosoma cruzi, is a devastating parasitic infection affecting
millions of people. Although many efforts have been made for the development of …

Stimulation of tumor-specific responses in both CD4+ and CD8+ T cells has been a
challenge for effective tumor vaccines. We designed a vaccine vector containing the AIDA-1 …

Vaccine-mediated Th1-biased CD4+ T cell responses have been shown to be crucial for
protection against Helicobacter pylori (H. pylori). In this study, we investigated whether a …

Candida auris is a globally emerging fungal pathogen responsible for causing nosocomial
outbreaks in healthcare associated settings. It is known to cause infection in all age groups …

Chronic gastric infection by the Gram-negative bacterium Helicobacter pylori (H. pylori) is
strongly associated with gastritis, gastric ulcer and the development of distal gastric …

Vaccination strategies for Staphylococcus aureus, particularly methicillin-resistant S. aureus
(MRSA) infections have attracted much research attention. Recent efforts have been made …